Social media in the times of COVID-19 A Goel, L Gupta JCR: Journal of Clinical Rheumatology 26 (6), 220-223, 2020 | 243 | 2020 |
A systematic review of smartphone applications available for corona virus disease 2019 (COVID19) and the assessment of their quality using the mobile application rating scale … S Davalbhakta, S Advani, S Kumar, V Agarwal, S Bhoyar, E Fedirko, ... Journal of medical systems 44, 1-15, 2020 | 209 | 2020 |
Information and misinformation on COVID-19: a cross-sectional survey study L Gupta, AY Gasparyan, DP Misra, V Agarwal, O Zimba, M Yessirkepov Journal of Korean medical science 35 (27), 2020 | 172 | 2020 |
COVID-19 and myositis: what we know so far A Saud, R Naveen, R Aggarwal, L Gupta Current rheumatology reports 23, 1-16, 2021 | 142 | 2021 |
Reporting survey based studies–a primer for authors PS Gaur, O Zimba, V Agarwal, L Gupta Journal of Korean medical science 35 (45), 2020 | 113 | 2020 |
Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States R Raiker, C DeYoung, H Pakhchanian, S Ahmed, C Kavadichanda, ... Seminars in arthritis and rheumatism 51 (5), 1057-1066, 2021 | 86 | 2021 |
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry P Mehta, PM Machado, L Gupta Rheumatology International 41 (6), 1021-1036, 2021 | 70 | 2021 |
Hyperinflammatory syndrome in children associated with COVID-19: need for awareness CS Bhat, L Gupta, S Balasubramanian, S Singh, AV Ramanan Indian pediatrics 57, 929-935, 2020 | 61 | 2020 |
Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India L Gupta, DP Misra, V Agarwal, S Balan, V Agarwal Annals of the rheumatic diseases 80 (1), e1-e1, 2021 | 56 | 2021 |
Sex hormones, autoimmunity and gender disparity in COVID-19 HA Raza, P Sen, OA Bhatti, L Gupta Rheumatology international 41 (8), 1375-1386, 2021 | 54 | 2021 |
COVID-19 and myositis–unique challenges for patients L Gupta, JB Lilleker, V Agarwal, H Chinoy, R Aggarwal Rheumatology 60 (2), 907-910, 2021 | 51 | 2021 |
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol P Sen, L Gupta, JB Lilleker, V Aggarwal, S Kardes, M Milchert, T Gheita, ... Rheumatology international 42 (1), 23-29, 2022 | 50 | 2022 |
Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis L Gupta, R Naveen, P Gaur, V Agarwal, R Aggarwal Seminars in arthritis and rheumatism 51 (1), 113-120, 2021 | 50 | 2021 |
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic R Naveen, TG Sundaram, V Agarwal, L Gupta Rheumatology International 41 (1), 67-76, 2021 | 48 | 2021 |
Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease L Gupta, S Bhattacharya, V Agarwal, A Aggarwal Clinical rheumatology 35 (12), 3075-3079, 2016 | 40 | 2016 |
COVID-19 and psychological disaster preparedness–an unmet need V Agarwal, S Sharma, L Gupta, DP Misra, S Davalbhakta, V Agarwal, ... Disaster medicine and public health preparedness 14 (3), 387-390, 2020 | 37 | 2020 |
Meeting report: MyoIN–Pan-India collaborative network for myositis research L Gupta, SK Appani, R Janardana, H Muhammed, A Lawrence, S Amin, ... Indian Journal of Rheumatology 14 (2), 136-142, 2019 | 36 | 2019 |
COVAD survey 2 long-term outcomes: unmet need and protocol ZZ Fazal, P Sen, M Joshi, N Ravichandran, JB Lilleker, V Agarwal, ... Rheumatology international 42 (12), 2151-2158, 2022 | 35 | 2022 |
COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 35 | 2022 |
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review D Gonzalez, L Gupta, V Murthy, EB Gonzalez, KA Williamson, A Makol, ... Rheumatology International 42 (9), 1629-1641, 2022 | 33 | 2022 |